Together in the fight against cervical cancer
Cervical Cancer screening and triage

Together in the fight against cervical cancer

HPV screening plays a vital role in the prevention of cervical cancer, which claims hundreds of thousands of lives each year.

The human papillomavirus (HPV) is an extremely common viral infection, impacting millions of people around the world. In fact, the United States Centers for Disease Control and Prevention says “HPV is so common that nearly all sexually active men and women get the virus at some point in their lives.”

At least 14 types of HPV are known to cause cervical cancer, which can be cured if detected early.

The road to cervical cancer control

The WHO plan to control cervical cancer relies on education and awareness for HPV prevention, screening, prompt treatment of HPV and any pre-cancerous or cancerous lesions. Effective vaccines are available for the types of HPV that most often lead to cervical cancer, and the WHO recommends that girls are vaccinated between the ages of 9-14, before they become sexually active.

Recommendations for HPV screening were updated by the WHO in 2021 to emphasize DNA-based tests rather than visual inspections as an objective, accurate diagnostic method.

Read the new WHO recommendations on screening and treatment to prevent cervical cancer.

The road to Cervical Cancer control

Talks from EUROGIN 2023